(WRB) W. R. Berkley - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US0844231029
WRB: Insurance, Reinsurance, Liability, Property, Casualty, Cyber
W. R. Berkley Corporation, a leading global insurance holding company, specializes in commercial lines insurance. Founded in 1967 and headquartered in Greenwich, Connecticut, Berkley operates through two primary segments: Insurance and Reinsurance & Monoline Excess.
The Insurance segment is a cornerstone of Berkleys operations, offering a diverse array of commercial insurance products. This includes excess and surplus lines for high-risk clients, admitted lines for standard risks, and specialty personal lines. Berkley also provides niche products such as cyber risk solutions, workers compensation, and professional liability insurance. Their offerings extend to specific industries like technology and life sciences, underscoring their tailored approach to meet varied client needs.
The Reinsurance & Monoline Excess segment further demonstrates Berkleys expertise. Here, they offer treaty and facultative reinsurance, aiding other insurers in managing risk. Additionally, Berkley provides specialized reinsurance products, including cyber liability and liquor liability, highlighting their ability to address emerging and unique risks effectively.
Financially, Berkley presents a robust profile with a market capitalization of $22.29 billion. Their P/E ratio stands at 13.49, with a forward P/E of 13.50, indicating a stable valuation. The price-to-book ratio of 2.66 and a price-to-sales ratio of 1.69 suggest a balance between growth and stability. These metrics are crucial for investors assessing Berkleys financial health and growth potential.
With a proven track record since 1967, W. R. Berkley Corporation has established itself as a reputable player in the insurance sector. Their commitment to disciplined underwriting and strategic growth positions them as a compelling choice for investors seeking stability and expertise in the dynamic insurance landscape. For more details, visit their website at https://www.berkley.com.
Additional Sources for WRB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
WRB Stock Overview
Market Cap in USD | 23,045m |
Sector | Financial Services |
Industry | Insurance - Property & Casualty |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 1984-09-07 |
WRB Stock Ratings
Growth 5y | 73.8% |
Fundamental | 71.3% |
Dividend | 64.7% |
Rel. Strength Industry | -13.7 |
Analysts | 3.81/5 |
Fair Price Momentum | 62.31 USD |
Fair Price DCF | 208.91 USD |
WRB Dividends
Dividend Yield 12m | 2.38% |
Yield on Cost 5y | 4.51% |
Annual Growth 5y | 46.22% |
Payout Consistency | 91.0% |
WRB Growth Ratios
Growth Correlation 3m | -19.2% |
Growth Correlation 12m | 77.4% |
Growth Correlation 5y | 93.7% |
CAGR 5y | 14.49% |
CAGR/Max DD 5y | 0.33 |
Sharpe Ratio 12m | 0.33 |
Alpha | 0.61 |
Beta | 0.29 |
Volatility | 21.13% |
Current Volume | 1639.5k |
Average Volume 20d | 1709.7k |
As of February 23, 2025, the stock is trading at USD 60.97 with a total of 1,639,492 shares traded.
Over the past week, the price has changed by +1.03%, over one month by +3.01%, over three months by -0.94% and over the past year by +12.26%.
Yes, based on ValueRay Fundamental Analyses, W. R. Berkley (NYSE:WRB) is currently (February 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 71.25 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WRB as of February 2025 is 62.31. This means that WRB is currently overvalued and has a potential downside of 2.2%.
W. R. Berkley has received a consensus analysts rating of 3.81. Therefor, it is recommend to buy WRB.
- Strong Buy: 7
- Buy: 1
- Hold: 6
- Sell: 2
- Strong Sell: 0
According to ValueRays Forecast Model, WRB W. R. Berkley will be worth about 70.1 in February 2026. The stock is currently trading at 60.97. This means that the stock has a potential upside of +15.02%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 63.5 | 4.2% |
Analysts Target Price | 64 | 5% |
ValueRay Target Price | 70.1 | 15% |